Humanigen (HGENQ) 10-Q2022 Q2 Quarterly report

Filed: 12 Aug 22, 4:18pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: alive, AML, azacitidine, blood, bore, Catalent, CBL, Clonal, commonly, comprehensive, cure, cytogenic, deemphasize, deployment, destroyed, destruction, DNA, Emanuel, enrichment, envisioned, expiry, extinguishing, extrapolated, Fisher, flow, genetic, Gupta, healthy, hyperresponsive, hypersensitivity, IIT, incidence, JMML, juvenile, leukaemia, leukemic, MDS, mentioned, MSA, multinational, myelodysplastic, myeloid, myeloproliferative, Orange, overproduction, Padron, people, Pharma, pharmacokinetic, PK, prepaid, principle, proof, proportion, rare, RAS, realigned, realignment, reconsidering, renegotiate, retiring, Retrieved, settle, shelf, SHIELD, shifted, Society, sponsorship, stored, Thermo, tolerability, traditionally, Unfair, unjust, Victorian, volunteer, waiver

Removed: abandon, accurately, advance, age, allege, alleged, Alliance, altogether, application, approve, bear, begin, beginning, BLA, borrowed, breached, broadly, caption, captioned, chemistry, CMO, commenced, committed, complaint, comprise, conditioned, confirm, contemplated, convert, cooperate, coupled, decision, deemed, defendant, deliver, derive, determine, disclose, distribution, Dr, duration, Durrant, dysfunction, elevated, equitable, EU, event, evolution, expand, expertise, expressly, extension, FDA, focused, Food, forecast, generated, governmental, greatest, inability, Index, individual, influence, insolvency, introduced, knockout, label, limit, limitation, lung, manufactured, maturity, mutual, newly, Noble, obtaining, occurred, offered, orderly, organ, pandemic, partner, placement, prejudice, prepare, present, preventing, prospective, protein, purpose, qualification, ranging, raw, recover, renew, repay, resulted, resulting, return, separate, service, source, state, strength, Supreme, syndrome, thousand, transitioned, treat, type, unfavorable, Union, utilizing, wind, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

HGENQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Timothy Morris, certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Humanigen, Inc. for the quarter ended June 30, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Humanigen, Inc.

Date: August 12, 2022

	By:	/s/ Timothy Morris
	Name:	Timothy Morris
	Title:	Chief Operating Officer and Chief
	Financial Officer
	(Principal Accounting and Financial Officer)